33152 Targeted combined endpoint improvement in patient and disease domains in atopic dermatitis (AD) among adults with moderate-to-severe AD treated with upadacitinib.
Autor: | Kwatra, Shawn G., De Bruin-Weller, Marjolein, Lio, Peter, Deleuran, Mette, Ofori, Sarah, Teixeira, Henrique D., Calimlim, Brian, Liu, Yingyi, Weidinger, Stephen |
---|---|
Zdroj: | Journal of the American Academy of Dermatology; 2022 Supplement, Vol. 87 Issue 3, pAB208-AB208, 1p |
Databáze: | Supplemental Index |
Externí odkaz: |